Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Payables (2023 - 2025)

Historic Payables for WORK Medical Technology (WOK) over the last 3 years, with Q3 2025 value amounting to $9.3 million.

  • WORK Medical Technology's Payables fell 4291.1% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 4291.1%. This contributed to the annual value of $9.3 million for FY2025, which is 4291.1% down from last year.
  • Latest data reveals that WORK Medical Technology reported Payables of $9.3 million as of Q3 2025, which was down 4291.1% from $12.9 million recorded in Q1 2025.
  • Over the past 5 years, WORK Medical Technology's Payables peaked at $16.3 million during Q3 2024, and registered a low of $9.3 million during Q3 2025.
  • Its 3-year average for Payables is $12.9 million, with a median of $13.1 million in 2023.
  • As far as peak fluctuations go, WORK Medical Technology's Payables soared by 2335.88% in 2024, and later tumbled by 4291.1% in 2025.
  • Over the past 3 years, WORK Medical Technology's Payables (Quarter) stood at $13.2 million in 2023, then rose by 23.36% to $16.3 million in 2024, then crashed by 42.91% to $9.3 million in 2025.
  • Its last three reported values are $9.3 million in Q3 2025, $12.9 million for Q1 2025, and $16.3 million during Q3 2024.